High peripheral T cell diversity is associated with lower risk of toxicity and superior response to dual immune checkpoint inhibitor therapy in patients with metastatic NSCLC - Concepedia

Concepedia

Publication | Open Access

High peripheral T cell diversity is associated with lower risk of toxicity and superior response to dual immune checkpoint inhibitor therapy in patients with metastatic NSCLC

DOI Full Paper Access

10

Citations

35

References

2024

Year

Mehmet Altan, Ruoxing Li, Ziyi Li, Runzhe Chen, Ajay Sheshadri, Hai T. Tran, Latasha Little, Joshua Baguley, Jefferson Sinson, Natalie I. Vokes,

Journal for ImmunoTherapy of Cancer

Abstract

NCT03391869.

References

	Year	Citations

Page 1